View ValuationKBC Corporation 향후 성장Future 기준 점검 5/6KBC은 연간 수입과 매출이 각각 140.3%와 69.2% 증가할 것으로 예상되고 EPS는 연간 140.4%만큼 증가할 것으로 예상됩니다.핵심 정보140.3%이익 성장률140.40%EPS 성장률Chemicals 이익 성장30.3%매출 성장률69.2%향후 자기자본이익률n/a애널리스트 커버리지Low마지막 업데이트01 Feb 2026최근 향후 성장 업데이트Price Target Changed • Sep 04Price target increased by 12% to CN¥29.70Up from CN¥26.47, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of CN¥30.90. Stock is up 96% over the past year. The company is forecast to post earnings per share of CN¥0.47 next year compared to a net loss per share of CN¥3.98 last year.Price Target Changed • Jan 17Price target decreased by 9.9% to CN¥26.48Down from CN¥29.40, the current price target is an average from 5 analysts. New target price is 30% above last closing price of CN¥20.37. Stock is down 50% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.97 last year.Price Target Changed • Dec 17Price target increased by 9.1% to CN¥32.09Up from CN¥29.40, the current price target is an average from 5 analysts. New target price is 38% above last closing price of CN¥23.19. Stock is down 42% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.97 last year.Price Target Changed • Aug 31Price target decreased by 7.2% to CN¥27.30Down from CN¥29.40, the current price target is an average from 4 analysts. New target price is 71% above last closing price of CN¥15.93. Stock is down 71% over the past year. The company is forecast to post earnings per share of CN¥1.14 for next year compared to CN¥0.97 last year.Major Estimate Revision • May 30Consensus EPS estimates fall by 27%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥1.88b to CN¥1.78b. EPS estimate also fell from CN¥2.31 per share to CN¥1.70 per share. Net income forecast to grow 852% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target down from CN¥56.06 to CN¥43.81. Share price fell 4.8% to CN¥35.60 over the past week.Major Estimate Revision • May 09Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥1.90b to CN¥1.87b. EPS estimate also fell from CN¥2.84 per share to CN¥2.47 per share. Net income forecast to grow 1,505% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target down from CN¥84.31 to CN¥69.31. Share price rose 5.7% to CN¥39.63 over the past week.모든 업데이트 보기Recent updates공시 • Apr 29KBC Corporation, Ltd., Annual General Meeting, May 20, 2026KBC Corporation, Ltd., Annual General Meeting, May 20, 2026, at 14:00 China Standard Time. Location: 1F, No. 79, Xiaoshitang Road, Yuelu District, Changsha, Hunan China공시 • Mar 30KBC Corporation, Ltd. to Report Q1, 2026 Results on Apr 29, 2026KBC Corporation, Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026Reported Earnings • Mar 05Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: CN¥6.77 loss per share (further deteriorated from CN¥3.98 loss in FY 2024). Revenue: CN¥822.9m (up 53% from FY 2024). Net loss: CN¥1.38b (loss widened 70% from FY 2024). Revenue missed analyst estimates by 40%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 62% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.공시 • Dec 26KBC Corporation, Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026KBC Corporation, Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026Reported Earnings • Oct 30Third quarter 2025 earnings released: CN¥0.53 loss per share (vs CN¥0.21 loss in 3Q 2024)Third quarter 2025 results: CN¥0.53 loss per share (further deteriorated from CN¥0.21 loss in 3Q 2024). Revenue: CN¥207.4m (up 113% from 3Q 2024). Net loss: CN¥107.8m (loss widened 152% from 3Q 2024). Revenue is forecast to grow 55% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.공시 • Sep 30KBC Corporation, Ltd. to Report Q3, 2025 Results on Oct 30, 2025KBC Corporation, Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025New Risk • Sep 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Price Target Changed • Sep 04Price target increased by 12% to CN¥29.70Up from CN¥26.47, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of CN¥30.90. Stock is up 96% over the past year. The company is forecast to post earnings per share of CN¥0.47 next year compared to a net loss per share of CN¥3.98 last year.공시 • Jun 30KBC Corporation, Ltd. to Report First Half, 2025 Results on Aug 29, 2025KBC Corporation, Ltd. announced that they will report first half, 2025 results on Aug 29, 2025공시 • Apr 29KBC Corporation, Ltd., Annual General Meeting, May 20, 2025KBC Corporation, Ltd., Annual General Meeting, May 20, 2025, at 14:00 China Standard Time.공시 • Mar 28KBC Corporation, Ltd. to Report Q1, 2025 Results on Apr 29, 2025KBC Corporation, Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025New Risk • Mar 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Reported Earnings • Mar 02Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: CN¥3.79 loss per share (down from CN¥0.97 profit in FY 2023). Revenue: CN¥538.2m (down 50% from FY 2023). Net loss: CN¥775.8m (down 483% from profit in FY 2023). Revenue missed analyst estimates by 45%. Earnings per share (EPS) also missed analyst estimates by 12%. Revenue is forecast to grow 66% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.분석 기사 • Feb 21KBC Corporation, Ltd.'s (SHSE:688598) P/S Is Still On The Mark Following 31% Share Price BounceThose holding KBC Corporation, Ltd. ( SHSE:688598 ) shares would be relieved that the share price has rebounded 31% in...Price Target Changed • Jan 17Price target decreased by 9.9% to CN¥26.48Down from CN¥29.40, the current price target is an average from 5 analysts. New target price is 30% above last closing price of CN¥20.37. Stock is down 50% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.97 last year.공시 • Dec 27KBC Corporation, Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025KBC Corporation, Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025분석 기사 • Dec 17Is KBC Corporation (SHSE:688598) Using Debt In A Risky Way?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...분석 기사 • Dec 17KBC Corporation, Ltd.'s (SHSE:688598) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of InvestorsKBC Corporation, Ltd. ( SHSE:688598 ) shares have retraced a considerable 26% in the last month, reversing a fair...Price Target Changed • Dec 17Price target increased by 9.1% to CN¥32.09Up from CN¥29.40, the current price target is an average from 5 analysts. New target price is 38% above last closing price of CN¥23.19. Stock is down 42% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.97 last year.Reported Earnings • Oct 30Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: CN¥0.21 loss per share (down from CN¥0.14 profit in 3Q 2023). Revenue: CN¥97.3m (down 64% from 3Q 2023). Net loss: CN¥42.8m (down 248% from profit in 3Q 2023). Revenue missed analyst estimates by 78%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 69% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 19 percentage points per year, which is a significant difference in performance.New Risk • Sep 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.공시 • Sep 30KBC Corporation, Ltd. to Report Q3, 2024 Results on Oct 30, 2024KBC Corporation, Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024분석 기사 • Sep 27Why Investors Shouldn't Be Surprised By KBC Corporation, Ltd.'s (SHSE:688598) 25% Share Price SurgeThose holding KBC Corporation, Ltd. ( SHSE:688598 ) shares would be relieved that the share price has rebounded 25% in...Price Target Changed • Aug 31Price target decreased by 7.2% to CN¥27.30Down from CN¥29.40, the current price target is an average from 4 analysts. New target price is 71% above last closing price of CN¥15.93. Stock is down 71% over the past year. The company is forecast to post earnings per share of CN¥1.14 for next year compared to CN¥0.97 last year.공시 • Aug 09KBC Corporation, Ltd. (SHSE:688598) commences an Equity Buyback Plan for CNY 20 million worth of its shares, under the authorization approved on August 6, 2024.KBC Corporation, Ltd. (SHSE:688598) commences share repurchases on August 8, 2024, under the program mandated by the shareholders in the Extraordinary General Meeting held on August 6, 2024. As per the mandate, the company is authorized to repurchase to repurchase CNY 20 million worth of its common shares. The shares will be repurchased at a price of not more than CNY 35 per share. The shares repurchased will be used to reduce registered capital, used for employee stock ownership plan or equity incentive, used to convert company convertible bonds and to maintain company value and shareholder rights. The program will be funded out of the company's own funds. The program will be valid till 1 months from the date of approval by shareholders, i.e., till September 5, 2024.공시 • Jun 28KBC Corporation, Ltd. to Report First Half, 2024 Results on Aug 30, 2024KBC Corporation, Ltd. announced that they will report first half, 2024 results on Aug 30, 2024분석 기사 • Jun 10Is KBC Corporation (SHSE:688598) Using Debt In A Risky Way?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Major Estimate Revision • May 30Consensus EPS estimates fall by 27%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥1.88b to CN¥1.78b. EPS estimate also fell from CN¥2.31 per share to CN¥1.70 per share. Net income forecast to grow 852% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target down from CN¥56.06 to CN¥43.81. Share price fell 4.8% to CN¥35.60 over the past week.Major Estimate Revision • May 09Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥1.90b to CN¥1.87b. EPS estimate also fell from CN¥2.84 per share to CN¥2.47 per share. Net income forecast to grow 1,505% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target down from CN¥84.31 to CN¥69.31. Share price rose 5.7% to CN¥39.63 over the past week.분석 기사 • May 06Some Investors May Be Willing To Look Past KBC Corporation's (SHSE:688598) Soft EarningsThe market for KBC Corporation, Ltd.'s ( SHSE:688598 ) shares didn't move much after it posted weak earnings recently...공시 • Apr 30KBC Corporation, Ltd., Annual General Meeting, May 20, 2024KBC Corporation, Ltd., Annual General Meeting, May 20, 2024, at 14:00 China Standard Time. Location: 1F, No. 79, Xiaoshitang Road, Yuelu District, Changsha, Hunan ChinaReported Earnings • Apr 29Full year 2023 earnings released: EPS: CN¥1.46 (vs CN¥4.36 in FY 2022)Full year 2023 results: EPS: CN¥1.46 (down from CN¥4.36 in FY 2022). Revenue: CN¥1.07b (down 26% from FY 2022). Net income: CN¥202.5m (down 63% from FY 2022). Profit margin: 19% (down from 38% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 65% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.분석 기사 • Apr 25Positive Sentiment Still Eludes KBC Corporation, Ltd. (SHSE:688598) Following 26% Share Price SlumpUnfortunately for some shareholders, the KBC Corporation, Ltd. ( SHSE:688598 ) share price has dived 26% in the last...Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to CN¥39.48, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 63% over the past three years.공시 • Mar 29KBC Corporation, Ltd. to Report Q1, 2024 Results on Apr 29, 2024KBC Corporation, Ltd. announced that they will report Q1, 2024 results on Apr 29, 2024Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥47.00, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 59% over the past three years.분석 기사 • Mar 07Market Participants Recognise KBC Corporation, Ltd.'s (SHSE:688598) Earnings Pushing Shares 34% HigherThose holding KBC Corporation, Ltd. ( SHSE:688598 ) shares would be relieved that the share price has rebounded 34% in...공시 • Feb 27KBC Corporation, Ltd. (SHSE:688598) commences an Equity Buyback Plan for CNY 100 million worth of its shares, under the authorization approved on February 23, 2024.KBC Corporation, Ltd. (SHSE:688598) commences share repurchases on February 26, 2024, under the program mandated by the shareholders in the Extraordinary General Meeting held on February 23, 2023. As per the mandate, the company is authorized to repurchase to repurchase CNY 100 million worth of its common shares. The shares will be repurchased at a price of not more than CNY 90 per share. The repurchased shares will be cancelled. The program will be funded out of the company's own funds. The program will be valid till 1 months from the date of approval by shareholders.Reported Earnings • Feb 24Full year 2023 earnings released: EPS: CN¥1.46 (vs CN¥4.36 in FY 2022)Full year 2023 results: EPS: CN¥1.46 (down from CN¥4.36 in FY 2022). Revenue: CN¥1.07b (down 26% from FY 2022). Net income: CN¥203.3m (down 63% from FY 2022). Profit margin: 19% (down from 38% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 55% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Jan 31Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥45.84, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 69% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥88.65 per share.New Risk • Jan 22New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 7.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.8% average weekly change). High level of non-cash earnings (41% accrual ratio).Buying Opportunity • Dec 08Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.6%. The fair value is estimated to be CN¥91.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 31% over the last 3 years. Earnings per share has grown by 23%. Revenue is forecast to grow by 201% in 2 years. Earnings is forecast to grow by 156% in the next 2 years.New Risk • Nov 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (41% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.9% average weekly change).Price Target Changed • Nov 04Price target decreased by 8.9% to CN¥111Down from CN¥122, the current price target is an average from 5 analysts. New target price is 45% above last closing price of CN¥76.50. Stock is down 57% over the past year. The company is forecast to post earnings per share of CN¥3.27 for next year compared to CN¥4.36 last year.Price Target Changed • Oct 27Price target decreased by 7.7% to CN¥113Down from CN¥122, the current price target is an average from 6 analysts. New target price is 35% above last closing price of CN¥83.20. Stock is down 47% over the past year. The company is forecast to post earnings per share of CN¥3.23 for next year compared to CN¥4.36 last year.Reported Earnings • Oct 24Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: EPS: CN¥0.21 (down from CN¥0.98 in 3Q 2022). Revenue: CN¥271.1m (down 9.7% from 3Q 2022). Net income: CN¥28.8m (down 78% from 3Q 2022). Profit margin: 11% (down from 43% in 3Q 2022). Revenue missed analyst estimates by 46%. Earnings per share (EPS) also missed analyst estimates by 84%. Revenue is forecast to grow 47% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.공시 • Sep 27KBC Corporation, Ltd. (SHSE:688598) announces an Equity Buyback for CNY 100 million worth of its shares.KBC Corporation, Ltd. (SHSE:688598) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The program will be valid for a period of 3 months.Major Estimate Revision • Aug 21Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥2.13b to CN¥2.06b. EPS estimate also fell from CN¥5.01 per share to CN¥4.36 per share. Net income forecast to grow 60% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target down from CN¥137 to CN¥125. Share price fell 7.6% to CN¥91.68 over the past week.Reported Earnings • Aug 15Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: CN¥1.20 (down from CN¥1.39 in 2Q 2022). Revenue: CN¥304.6m (down 23% from 2Q 2022). Net income: CN¥165.1m (flat on 2Q 2022). Profit margin: 54% (up from 42% in 2Q 2022). Revenue missed analyst estimates by 24%. Earnings per share (EPS) also missed analyst estimates by 18%. Revenue is forecast to grow 40% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.공시 • Jun 28KBC Corporation, Ltd. to Report First Half, 2023 Results on Aug 29, 2023KBC Corporation, Ltd. announced that they will report first half, 2023 results on Aug 29, 2023New Risk • Jun 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (53% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding).공시 • May 30KBC Corporation, Ltd. (SHSE:688598) announces an Equity Buyback for CNY 100 million worth of its shares.KBC Corporation, Ltd. (SHSE:688598) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The program will be valid for a period of 3 months.Major Estimate Revision • May 10Consensus revenue estimates increase by 14%, EPS downgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from CN¥1.85b to CN¥2.12b. EPS estimate fell from CN¥7.41 to CN¥7.19. Net income forecast to grow 61% next year vs 54% growth forecast for Chemicals industry in China. Consensus price target down from CN¥241 to CN¥218. Share price fell 9.0% to CN¥160 over the past week.Reported Earnings • Apr 22Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: CN¥6.45 (up from CN¥6.26 in FY 2021). Revenue: CN¥1.45b (up 8.4% from FY 2021). Net income: CN¥551.2m (up 10.0% from FY 2021). Profit margin: 38% (in line with FY 2021). Revenue missed analyst estimates by 11%. Earnings per share (EPS) also missed analyst estimates by 9.2%. Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.Reported Earnings • Mar 01Full year 2022 earnings released: EPS: CN¥6.45 (vs CN¥6.26 in FY 2021)Full year 2022 results: EPS: CN¥6.45 (up from CN¥6.26 in FY 2021). Revenue: CN¥1.45b (up 8.4% from FY 2021). Net income: CN¥551.2m (up 10.0% from FY 2021). Profit margin: 38% (in line with FY 2021). Revenue is forecast to grow 38% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China.Price Target Changed • Nov 16Price target decreased to CN¥306Down from CN¥348, the current price target is an average from 2 analysts. New target price is 22% above last closing price of CN¥250. Stock is down 24% over the past year. The company is forecast to post earnings per share of CN¥7.11 for next year compared to CN¥6.26 last year.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Hongbo Liu was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥265, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 23% over the past year.Reported Earnings • Oct 30Third quarter 2022 earnings released: EPS: CN¥1.46 (vs CN¥1.63 in 3Q 2021)Third quarter 2022 results: EPS: CN¥1.46 (down from CN¥1.63 in 3Q 2021). Revenue: CN¥300.2m (down 20% from 3Q 2021). Net income: CN¥128.8m (down 1.3% from 3Q 2021). Profit margin: 43% (up from 35% in 3Q 2021). The increase in margin was driven by lower expenses. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.공시 • Sep 16KBC Corporation, Ltd. (SHSE:688598) announces an Equity Buyback for CNY 200 million worth of its shares.KBC Corporation, Ltd. (SHSE:688598) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of its shares. The program is valid for 6 months.Major Estimate Revision • Sep 02Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from CN¥8.07 to CN¥7.09 per share. Revenue forecast steady at CN¥1.80b. Net income forecast to grow 12% next year vs 39% growth forecast for Chemicals industry in China. Consensus price target of CN¥365 unchanged from last update. Share price fell 11% to CN¥284 over the past week.Reported Earnings • Aug 29Second quarter 2022 earnings released: EPS: CN¥2.06 (vs CN¥1.58 in 2Q 2021)Second quarter 2022 results: EPS: CN¥2.06 (up from CN¥1.58 in 2Q 2021). Revenue: CN¥396.3m (up 27% from 2Q 2021). Net income: CN¥165.3m (up 30% from 2Q 2021). Profit margin: 42% (up from 41% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 26%, compared to a 40% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Aug 01Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥381, the stock trades at a forward P/E ratio of 44x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 42% over the past year.Valuation Update With 7 Day Price Move • Jul 15Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥330, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 15% over the past year.Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥272, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 37% over the past year.Price Target Changed • Jun 01Price target decreased to CN¥365Down from CN¥394, the current price target is an average from 3 analysts. New target price is 49% above last closing price of CN¥245. Stock is up 17% over the past year. The company is forecast to post earnings per share of CN¥8.07 for next year compared to CN¥6.26 last year.Valuation Update With 7 Day Price Move • May 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥214, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 21% over the past year.Reported Earnings • Apr 27First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: CN¥2.53 (up from CN¥0.97 in 1Q 2021). Revenue: CN¥450.2m (up 126% from 1Q 2021). Net income: CN¥202.7m (up 163% from 1Q 2021). Profit margin: 45% (up from 39% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 9.7%. Earnings per share (EPS) also surpassed analyst estimates by 8.9%. Over the next year, revenue is forecast to grow 21%, compared to a 43% growth forecast for the industry in China.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Hongbo Liu was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Apr 26KBC Corporation, Ltd. (SHSE:688598) announces an Equity Buyback for CNY 100 million worth of its shares.KBC Corporation, Ltd. (SHSE:688598) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The program is valid for 2 months.Major Estimate Revision • Mar 15Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast fell from CN¥2.02b to CN¥1.75b. EPS estimate unchanged from CN¥8.07 per share at last update. Chemicals industry in China expected to see average net income growth of 47% next year. Consensus price target of CN¥400 unchanged from last update. Share price rose 9.9% to CN¥238 over the past week.Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to CN¥222, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 43% over the past year.Reported Earnings • Feb 27Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: CN¥6.26 (up from CN¥2.35 in FY 2020). Revenue: CN¥1.34b (up 214% from FY 2020). Net income: CN¥501.1m (up 197% from FY 2020). Profit margin: 38% (down from 40% in FY 2020). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 9.7%. Earnings per share (EPS) also surpassed analyst estimates by 8.9%. Over the next year, revenue is forecast to grow 27%, compared to a 47% growth forecast for the industry in China.Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥1.63 (vs CN¥0.59 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥375.9m (up 264% from 3Q 2020). Net income: CN¥130.4m (up 220% from 3Q 2020). Profit margin: 35% (down from 40% in 3Q 2020). The decrease in margin was driven by higher expenses.Price Target Changed • Aug 29Price target increased to CN¥366Up from CN¥266, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of CN¥374. Stock is up 258% over the past year.Reported Earnings • Aug 25Second quarter 2021 earnings released: EPS CN¥1.58 (vs CN¥0.48 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥312.7m (up 234% from 2Q 2020). Net income: CN¥126.8m (up 294% from 2Q 2020). Profit margin: 41% (up from 34% in 2Q 2020). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥204, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 115% over the past year.Valuation Update With 7 Day Price Move • May 10Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥148, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 18x in the Chemicals industry in China.Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.97 (vs CN¥0.69 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥199.4m (up 118% from 1Q 2020). Net income: CN¥77.2m (up 87% from 1Q 2020). Profit margin: 39% (down from 45% in 1Q 2020). The decrease in margin was driven by higher expenses.Reported Earnings • Apr 02Full year 2020 earnings released: EPS CN¥2.35 (vs CN¥1.32 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥426.5m (up 78% from FY 2019). Net income: CN¥168.6m (up 117% from FY 2019). Profit margin: 40% (up from 32% in FY 2019). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Mar 09Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to CN¥149, the stock is trading at a trailing P/E ratio of 63.5x, down from the previous P/E ratio of 77.5x. This compares to an average P/E of 36x in the Chemicals industry in China.Is New 90 Day High Low • Jan 22New 90-day high: CN¥235The company is up 103% from its price of CN¥116 on 23 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 23% over the same period.Is New 90 Day High Low • Dec 30New 90-day high: CN¥222The company is up 121% from its price of CN¥100 on 30 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.Is New 90 Day High Low • Dec 10New 90-day high: CN¥126The company is up 24% from its price of CN¥101 on 11 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.Is New 90 Day High Low • Nov 04New 90-day high: CN¥125The company is up 19% from its price of CN¥105 on 06 August 2020. The Chinese market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 3.0% over the same period.공시 • Oct 19KBC Corporation, Ltd. to Report Q3, 2020 Results on Oct 23, 2020KBC Corporation, Ltd. announced that they will report Q3, 2020 results on Oct 23, 2020Is New 90 Day High Low • Oct 12New 90-day high: CN¥118The company is up 15% from its price of CN¥102 on 14 July 2020. The Chinese market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period.Valuation Update With 7 Day Price Move • Oct 12Market bids up stock over the past weekAfter last week's 18% share price gain to CN¥118, the stock is trading at a trailing P/E ratio of 69.9x, up from the previous P/E ratio of 59.3x. This compares to an average P/E of 39x in the Chemicals industry in China.공시 • Jul 06KBC Corporation, Ltd. to Report First Half, 2020 Results on Aug 12, 2020KBC Corporation, Ltd. announced that they will report first half, 2020 results on Aug 12, 2020이익 및 매출 성장 예측SHSE:688598 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20273,866395N/A563112/31/20262,620273N/A53713/31/2026854-1,275-487-228N/A12/31/2025803-1,281-471-140N/A9/30/2025715-945-44729N/A6/30/2025604-880-378122N/A3/31/2025494-846-272233N/A12/31/2024537-815-600198N/A9/30/2024634-255-8221N/A6/30/2024808-184-953-93N/A3/31/202497230-1,25658N/A12/31/20231,072202-1,098208N/A9/30/20231,181366-1,050297N/A6/30/20231,210466-1,125365N/A3/31/20231,302467-1,013387N/A12/31/20221,450551-710495N/A9/30/20221,597663-523527N/A6/30/20221,672665-473434N/A3/31/20221,589627-432259N/A12/31/20211,338501-57467N/A9/30/20211,026389-639-69N/A6/30/2021753299-4809N/A3/31/2021534204-361-16N/A12/31/2020426169-18441N/A9/30/2020338121-12511N/A6/30/2020303104-2239N/A3/31/2020267931335N/A12/31/201924078N/A-6N/A12/31/201818054N/A32N/A12/31/201714229N/A6N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 688598 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(2.4%)보다 빠른 성장으로 간주됩니다.수익 vs 시장: 688598 (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.고성장 수익: 688598 향후 3년 내에 수익을 낼 것으로 예상됩니다.수익 대 시장: 688598 의 수익(연간 69.2%)이 CN 시장(연간 16.2%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: 688598 의 수익(연간 69.2%)은 연간 20%보다 빠르게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 688598의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 21:13종가2026/05/21 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스KBC Corporation, Ltd.는 5명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Xianfan ChenChina International Capital Corporation LimitedBai Qiao XuHaitong International Research LimitedJun LiuHuatai Research2명의 분석가 더 보기
Price Target Changed • Sep 04Price target increased by 12% to CN¥29.70Up from CN¥26.47, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of CN¥30.90. Stock is up 96% over the past year. The company is forecast to post earnings per share of CN¥0.47 next year compared to a net loss per share of CN¥3.98 last year.
Price Target Changed • Jan 17Price target decreased by 9.9% to CN¥26.48Down from CN¥29.40, the current price target is an average from 5 analysts. New target price is 30% above last closing price of CN¥20.37. Stock is down 50% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.97 last year.
Price Target Changed • Dec 17Price target increased by 9.1% to CN¥32.09Up from CN¥29.40, the current price target is an average from 5 analysts. New target price is 38% above last closing price of CN¥23.19. Stock is down 42% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.97 last year.
Price Target Changed • Aug 31Price target decreased by 7.2% to CN¥27.30Down from CN¥29.40, the current price target is an average from 4 analysts. New target price is 71% above last closing price of CN¥15.93. Stock is down 71% over the past year. The company is forecast to post earnings per share of CN¥1.14 for next year compared to CN¥0.97 last year.
Major Estimate Revision • May 30Consensus EPS estimates fall by 27%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥1.88b to CN¥1.78b. EPS estimate also fell from CN¥2.31 per share to CN¥1.70 per share. Net income forecast to grow 852% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target down from CN¥56.06 to CN¥43.81. Share price fell 4.8% to CN¥35.60 over the past week.
Major Estimate Revision • May 09Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥1.90b to CN¥1.87b. EPS estimate also fell from CN¥2.84 per share to CN¥2.47 per share. Net income forecast to grow 1,505% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target down from CN¥84.31 to CN¥69.31. Share price rose 5.7% to CN¥39.63 over the past week.
공시 • Apr 29KBC Corporation, Ltd., Annual General Meeting, May 20, 2026KBC Corporation, Ltd., Annual General Meeting, May 20, 2026, at 14:00 China Standard Time. Location: 1F, No. 79, Xiaoshitang Road, Yuelu District, Changsha, Hunan China
공시 • Mar 30KBC Corporation, Ltd. to Report Q1, 2026 Results on Apr 29, 2026KBC Corporation, Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026
Reported Earnings • Mar 05Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: CN¥6.77 loss per share (further deteriorated from CN¥3.98 loss in FY 2024). Revenue: CN¥822.9m (up 53% from FY 2024). Net loss: CN¥1.38b (loss widened 70% from FY 2024). Revenue missed analyst estimates by 40%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 62% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.
공시 • Dec 26KBC Corporation, Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026KBC Corporation, Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026
Reported Earnings • Oct 30Third quarter 2025 earnings released: CN¥0.53 loss per share (vs CN¥0.21 loss in 3Q 2024)Third quarter 2025 results: CN¥0.53 loss per share (further deteriorated from CN¥0.21 loss in 3Q 2024). Revenue: CN¥207.4m (up 113% from 3Q 2024). Net loss: CN¥107.8m (loss widened 152% from 3Q 2024). Revenue is forecast to grow 55% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.
공시 • Sep 30KBC Corporation, Ltd. to Report Q3, 2025 Results on Oct 30, 2025KBC Corporation, Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025
New Risk • Sep 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Price Target Changed • Sep 04Price target increased by 12% to CN¥29.70Up from CN¥26.47, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of CN¥30.90. Stock is up 96% over the past year. The company is forecast to post earnings per share of CN¥0.47 next year compared to a net loss per share of CN¥3.98 last year.
공시 • Jun 30KBC Corporation, Ltd. to Report First Half, 2025 Results on Aug 29, 2025KBC Corporation, Ltd. announced that they will report first half, 2025 results on Aug 29, 2025
공시 • Apr 29KBC Corporation, Ltd., Annual General Meeting, May 20, 2025KBC Corporation, Ltd., Annual General Meeting, May 20, 2025, at 14:00 China Standard Time.
공시 • Mar 28KBC Corporation, Ltd. to Report Q1, 2025 Results on Apr 29, 2025KBC Corporation, Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025
New Risk • Mar 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Reported Earnings • Mar 02Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: CN¥3.79 loss per share (down from CN¥0.97 profit in FY 2023). Revenue: CN¥538.2m (down 50% from FY 2023). Net loss: CN¥775.8m (down 483% from profit in FY 2023). Revenue missed analyst estimates by 45%. Earnings per share (EPS) also missed analyst estimates by 12%. Revenue is forecast to grow 66% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.
분석 기사 • Feb 21KBC Corporation, Ltd.'s (SHSE:688598) P/S Is Still On The Mark Following 31% Share Price BounceThose holding KBC Corporation, Ltd. ( SHSE:688598 ) shares would be relieved that the share price has rebounded 31% in...
Price Target Changed • Jan 17Price target decreased by 9.9% to CN¥26.48Down from CN¥29.40, the current price target is an average from 5 analysts. New target price is 30% above last closing price of CN¥20.37. Stock is down 50% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.97 last year.
공시 • Dec 27KBC Corporation, Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025KBC Corporation, Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025
분석 기사 • Dec 17Is KBC Corporation (SHSE:688598) Using Debt In A Risky Way?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
분석 기사 • Dec 17KBC Corporation, Ltd.'s (SHSE:688598) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of InvestorsKBC Corporation, Ltd. ( SHSE:688598 ) shares have retraced a considerable 26% in the last month, reversing a fair...
Price Target Changed • Dec 17Price target increased by 9.1% to CN¥32.09Up from CN¥29.40, the current price target is an average from 5 analysts. New target price is 38% above last closing price of CN¥23.19. Stock is down 42% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.97 last year.
Reported Earnings • Oct 30Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: CN¥0.21 loss per share (down from CN¥0.14 profit in 3Q 2023). Revenue: CN¥97.3m (down 64% from 3Q 2023). Net loss: CN¥42.8m (down 248% from profit in 3Q 2023). Revenue missed analyst estimates by 78%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 69% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 19 percentage points per year, which is a significant difference in performance.
New Risk • Sep 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
공시 • Sep 30KBC Corporation, Ltd. to Report Q3, 2024 Results on Oct 30, 2024KBC Corporation, Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024
분석 기사 • Sep 27Why Investors Shouldn't Be Surprised By KBC Corporation, Ltd.'s (SHSE:688598) 25% Share Price SurgeThose holding KBC Corporation, Ltd. ( SHSE:688598 ) shares would be relieved that the share price has rebounded 25% in...
Price Target Changed • Aug 31Price target decreased by 7.2% to CN¥27.30Down from CN¥29.40, the current price target is an average from 4 analysts. New target price is 71% above last closing price of CN¥15.93. Stock is down 71% over the past year. The company is forecast to post earnings per share of CN¥1.14 for next year compared to CN¥0.97 last year.
공시 • Aug 09KBC Corporation, Ltd. (SHSE:688598) commences an Equity Buyback Plan for CNY 20 million worth of its shares, under the authorization approved on August 6, 2024.KBC Corporation, Ltd. (SHSE:688598) commences share repurchases on August 8, 2024, under the program mandated by the shareholders in the Extraordinary General Meeting held on August 6, 2024. As per the mandate, the company is authorized to repurchase to repurchase CNY 20 million worth of its common shares. The shares will be repurchased at a price of not more than CNY 35 per share. The shares repurchased will be used to reduce registered capital, used for employee stock ownership plan or equity incentive, used to convert company convertible bonds and to maintain company value and shareholder rights. The program will be funded out of the company's own funds. The program will be valid till 1 months from the date of approval by shareholders, i.e., till September 5, 2024.
공시 • Jun 28KBC Corporation, Ltd. to Report First Half, 2024 Results on Aug 30, 2024KBC Corporation, Ltd. announced that they will report first half, 2024 results on Aug 30, 2024
분석 기사 • Jun 10Is KBC Corporation (SHSE:688598) Using Debt In A Risky Way?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Major Estimate Revision • May 30Consensus EPS estimates fall by 27%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥1.88b to CN¥1.78b. EPS estimate also fell from CN¥2.31 per share to CN¥1.70 per share. Net income forecast to grow 852% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target down from CN¥56.06 to CN¥43.81. Share price fell 4.8% to CN¥35.60 over the past week.
Major Estimate Revision • May 09Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥1.90b to CN¥1.87b. EPS estimate also fell from CN¥2.84 per share to CN¥2.47 per share. Net income forecast to grow 1,505% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target down from CN¥84.31 to CN¥69.31. Share price rose 5.7% to CN¥39.63 over the past week.
분석 기사 • May 06Some Investors May Be Willing To Look Past KBC Corporation's (SHSE:688598) Soft EarningsThe market for KBC Corporation, Ltd.'s ( SHSE:688598 ) shares didn't move much after it posted weak earnings recently...
공시 • Apr 30KBC Corporation, Ltd., Annual General Meeting, May 20, 2024KBC Corporation, Ltd., Annual General Meeting, May 20, 2024, at 14:00 China Standard Time. Location: 1F, No. 79, Xiaoshitang Road, Yuelu District, Changsha, Hunan China
Reported Earnings • Apr 29Full year 2023 earnings released: EPS: CN¥1.46 (vs CN¥4.36 in FY 2022)Full year 2023 results: EPS: CN¥1.46 (down from CN¥4.36 in FY 2022). Revenue: CN¥1.07b (down 26% from FY 2022). Net income: CN¥202.5m (down 63% from FY 2022). Profit margin: 19% (down from 38% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 65% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.
분석 기사 • Apr 25Positive Sentiment Still Eludes KBC Corporation, Ltd. (SHSE:688598) Following 26% Share Price SlumpUnfortunately for some shareholders, the KBC Corporation, Ltd. ( SHSE:688598 ) share price has dived 26% in the last...
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to CN¥39.48, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 63% over the past three years.
공시 • Mar 29KBC Corporation, Ltd. to Report Q1, 2024 Results on Apr 29, 2024KBC Corporation, Ltd. announced that they will report Q1, 2024 results on Apr 29, 2024
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥47.00, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 59% over the past three years.
분석 기사 • Mar 07Market Participants Recognise KBC Corporation, Ltd.'s (SHSE:688598) Earnings Pushing Shares 34% HigherThose holding KBC Corporation, Ltd. ( SHSE:688598 ) shares would be relieved that the share price has rebounded 34% in...
공시 • Feb 27KBC Corporation, Ltd. (SHSE:688598) commences an Equity Buyback Plan for CNY 100 million worth of its shares, under the authorization approved on February 23, 2024.KBC Corporation, Ltd. (SHSE:688598) commences share repurchases on February 26, 2024, under the program mandated by the shareholders in the Extraordinary General Meeting held on February 23, 2023. As per the mandate, the company is authorized to repurchase to repurchase CNY 100 million worth of its common shares. The shares will be repurchased at a price of not more than CNY 90 per share. The repurchased shares will be cancelled. The program will be funded out of the company's own funds. The program will be valid till 1 months from the date of approval by shareholders.
Reported Earnings • Feb 24Full year 2023 earnings released: EPS: CN¥1.46 (vs CN¥4.36 in FY 2022)Full year 2023 results: EPS: CN¥1.46 (down from CN¥4.36 in FY 2022). Revenue: CN¥1.07b (down 26% from FY 2022). Net income: CN¥203.3m (down 63% from FY 2022). Profit margin: 19% (down from 38% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 55% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Jan 31Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥45.84, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 69% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥88.65 per share.
New Risk • Jan 22New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 7.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.8% average weekly change). High level of non-cash earnings (41% accrual ratio).
Buying Opportunity • Dec 08Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.6%. The fair value is estimated to be CN¥91.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 31% over the last 3 years. Earnings per share has grown by 23%. Revenue is forecast to grow by 201% in 2 years. Earnings is forecast to grow by 156% in the next 2 years.
New Risk • Nov 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (41% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.9% average weekly change).
Price Target Changed • Nov 04Price target decreased by 8.9% to CN¥111Down from CN¥122, the current price target is an average from 5 analysts. New target price is 45% above last closing price of CN¥76.50. Stock is down 57% over the past year. The company is forecast to post earnings per share of CN¥3.27 for next year compared to CN¥4.36 last year.
Price Target Changed • Oct 27Price target decreased by 7.7% to CN¥113Down from CN¥122, the current price target is an average from 6 analysts. New target price is 35% above last closing price of CN¥83.20. Stock is down 47% over the past year. The company is forecast to post earnings per share of CN¥3.23 for next year compared to CN¥4.36 last year.
Reported Earnings • Oct 24Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: EPS: CN¥0.21 (down from CN¥0.98 in 3Q 2022). Revenue: CN¥271.1m (down 9.7% from 3Q 2022). Net income: CN¥28.8m (down 78% from 3Q 2022). Profit margin: 11% (down from 43% in 3Q 2022). Revenue missed analyst estimates by 46%. Earnings per share (EPS) also missed analyst estimates by 84%. Revenue is forecast to grow 47% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
공시 • Sep 27KBC Corporation, Ltd. (SHSE:688598) announces an Equity Buyback for CNY 100 million worth of its shares.KBC Corporation, Ltd. (SHSE:688598) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The program will be valid for a period of 3 months.
Major Estimate Revision • Aug 21Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥2.13b to CN¥2.06b. EPS estimate also fell from CN¥5.01 per share to CN¥4.36 per share. Net income forecast to grow 60% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target down from CN¥137 to CN¥125. Share price fell 7.6% to CN¥91.68 over the past week.
Reported Earnings • Aug 15Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: CN¥1.20 (down from CN¥1.39 in 2Q 2022). Revenue: CN¥304.6m (down 23% from 2Q 2022). Net income: CN¥165.1m (flat on 2Q 2022). Profit margin: 54% (up from 42% in 2Q 2022). Revenue missed analyst estimates by 24%. Earnings per share (EPS) also missed analyst estimates by 18%. Revenue is forecast to grow 40% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
공시 • Jun 28KBC Corporation, Ltd. to Report First Half, 2023 Results on Aug 29, 2023KBC Corporation, Ltd. announced that they will report first half, 2023 results on Aug 29, 2023
New Risk • Jun 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (53% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding).
공시 • May 30KBC Corporation, Ltd. (SHSE:688598) announces an Equity Buyback for CNY 100 million worth of its shares.KBC Corporation, Ltd. (SHSE:688598) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The program will be valid for a period of 3 months.
Major Estimate Revision • May 10Consensus revenue estimates increase by 14%, EPS downgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from CN¥1.85b to CN¥2.12b. EPS estimate fell from CN¥7.41 to CN¥7.19. Net income forecast to grow 61% next year vs 54% growth forecast for Chemicals industry in China. Consensus price target down from CN¥241 to CN¥218. Share price fell 9.0% to CN¥160 over the past week.
Reported Earnings • Apr 22Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: CN¥6.45 (up from CN¥6.26 in FY 2021). Revenue: CN¥1.45b (up 8.4% from FY 2021). Net income: CN¥551.2m (up 10.0% from FY 2021). Profit margin: 38% (in line with FY 2021). Revenue missed analyst estimates by 11%. Earnings per share (EPS) also missed analyst estimates by 9.2%. Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.
Reported Earnings • Mar 01Full year 2022 earnings released: EPS: CN¥6.45 (vs CN¥6.26 in FY 2021)Full year 2022 results: EPS: CN¥6.45 (up from CN¥6.26 in FY 2021). Revenue: CN¥1.45b (up 8.4% from FY 2021). Net income: CN¥551.2m (up 10.0% from FY 2021). Profit margin: 38% (in line with FY 2021). Revenue is forecast to grow 38% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China.
Price Target Changed • Nov 16Price target decreased to CN¥306Down from CN¥348, the current price target is an average from 2 analysts. New target price is 22% above last closing price of CN¥250. Stock is down 24% over the past year. The company is forecast to post earnings per share of CN¥7.11 for next year compared to CN¥6.26 last year.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Hongbo Liu was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥265, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 23% over the past year.
Reported Earnings • Oct 30Third quarter 2022 earnings released: EPS: CN¥1.46 (vs CN¥1.63 in 3Q 2021)Third quarter 2022 results: EPS: CN¥1.46 (down from CN¥1.63 in 3Q 2021). Revenue: CN¥300.2m (down 20% from 3Q 2021). Net income: CN¥128.8m (down 1.3% from 3Q 2021). Profit margin: 43% (up from 35% in 3Q 2021). The increase in margin was driven by lower expenses. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
공시 • Sep 16KBC Corporation, Ltd. (SHSE:688598) announces an Equity Buyback for CNY 200 million worth of its shares.KBC Corporation, Ltd. (SHSE:688598) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of its shares. The program is valid for 6 months.
Major Estimate Revision • Sep 02Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from CN¥8.07 to CN¥7.09 per share. Revenue forecast steady at CN¥1.80b. Net income forecast to grow 12% next year vs 39% growth forecast for Chemicals industry in China. Consensus price target of CN¥365 unchanged from last update. Share price fell 11% to CN¥284 over the past week.
Reported Earnings • Aug 29Second quarter 2022 earnings released: EPS: CN¥2.06 (vs CN¥1.58 in 2Q 2021)Second quarter 2022 results: EPS: CN¥2.06 (up from CN¥1.58 in 2Q 2021). Revenue: CN¥396.3m (up 27% from 2Q 2021). Net income: CN¥165.3m (up 30% from 2Q 2021). Profit margin: 42% (up from 41% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 26%, compared to a 40% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Aug 01Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥381, the stock trades at a forward P/E ratio of 44x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 42% over the past year.
Valuation Update With 7 Day Price Move • Jul 15Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥330, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 15% over the past year.
Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥272, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 37% over the past year.
Price Target Changed • Jun 01Price target decreased to CN¥365Down from CN¥394, the current price target is an average from 3 analysts. New target price is 49% above last closing price of CN¥245. Stock is up 17% over the past year. The company is forecast to post earnings per share of CN¥8.07 for next year compared to CN¥6.26 last year.
Valuation Update With 7 Day Price Move • May 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥214, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 21% over the past year.
Reported Earnings • Apr 27First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: CN¥2.53 (up from CN¥0.97 in 1Q 2021). Revenue: CN¥450.2m (up 126% from 1Q 2021). Net income: CN¥202.7m (up 163% from 1Q 2021). Profit margin: 45% (up from 39% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 9.7%. Earnings per share (EPS) also surpassed analyst estimates by 8.9%. Over the next year, revenue is forecast to grow 21%, compared to a 43% growth forecast for the industry in China.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Hongbo Liu was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Apr 26KBC Corporation, Ltd. (SHSE:688598) announces an Equity Buyback for CNY 100 million worth of its shares.KBC Corporation, Ltd. (SHSE:688598) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The program is valid for 2 months.
Major Estimate Revision • Mar 15Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast fell from CN¥2.02b to CN¥1.75b. EPS estimate unchanged from CN¥8.07 per share at last update. Chemicals industry in China expected to see average net income growth of 47% next year. Consensus price target of CN¥400 unchanged from last update. Share price rose 9.9% to CN¥238 over the past week.
Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorated over the past weekAfter last week's 23% share price decline to CN¥222, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 43% over the past year.
Reported Earnings • Feb 27Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: CN¥6.26 (up from CN¥2.35 in FY 2020). Revenue: CN¥1.34b (up 214% from FY 2020). Net income: CN¥501.1m (up 197% from FY 2020). Profit margin: 38% (down from 40% in FY 2020). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 9.7%. Earnings per share (EPS) also surpassed analyst estimates by 8.9%. Over the next year, revenue is forecast to grow 27%, compared to a 47% growth forecast for the industry in China.
Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥1.63 (vs CN¥0.59 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥375.9m (up 264% from 3Q 2020). Net income: CN¥130.4m (up 220% from 3Q 2020). Profit margin: 35% (down from 40% in 3Q 2020). The decrease in margin was driven by higher expenses.
Price Target Changed • Aug 29Price target increased to CN¥366Up from CN¥266, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of CN¥374. Stock is up 258% over the past year.
Reported Earnings • Aug 25Second quarter 2021 earnings released: EPS CN¥1.58 (vs CN¥0.48 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥312.7m (up 234% from 2Q 2020). Net income: CN¥126.8m (up 294% from 2Q 2020). Profit margin: 41% (up from 34% in 2Q 2020). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥204, the stock trades at a forward P/E ratio of 38x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 115% over the past year.
Valuation Update With 7 Day Price Move • May 10Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥148, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 18x in the Chemicals industry in China.
Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.97 (vs CN¥0.69 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥199.4m (up 118% from 1Q 2020). Net income: CN¥77.2m (up 87% from 1Q 2020). Profit margin: 39% (down from 45% in 1Q 2020). The decrease in margin was driven by higher expenses.
Reported Earnings • Apr 02Full year 2020 earnings released: EPS CN¥2.35 (vs CN¥1.32 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥426.5m (up 78% from FY 2019). Net income: CN¥168.6m (up 117% from FY 2019). Profit margin: 40% (up from 32% in FY 2019). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Mar 09Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to CN¥149, the stock is trading at a trailing P/E ratio of 63.5x, down from the previous P/E ratio of 77.5x. This compares to an average P/E of 36x in the Chemicals industry in China.
Is New 90 Day High Low • Jan 22New 90-day high: CN¥235The company is up 103% from its price of CN¥116 on 23 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 23% over the same period.
Is New 90 Day High Low • Dec 30New 90-day high: CN¥222The company is up 121% from its price of CN¥100 on 30 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.
Is New 90 Day High Low • Dec 10New 90-day high: CN¥126The company is up 24% from its price of CN¥101 on 11 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.
Is New 90 Day High Low • Nov 04New 90-day high: CN¥125The company is up 19% from its price of CN¥105 on 06 August 2020. The Chinese market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 3.0% over the same period.
공시 • Oct 19KBC Corporation, Ltd. to Report Q3, 2020 Results on Oct 23, 2020KBC Corporation, Ltd. announced that they will report Q3, 2020 results on Oct 23, 2020
Is New 90 Day High Low • Oct 12New 90-day high: CN¥118The company is up 15% from its price of CN¥102 on 14 July 2020. The Chinese market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period.
Valuation Update With 7 Day Price Move • Oct 12Market bids up stock over the past weekAfter last week's 18% share price gain to CN¥118, the stock is trading at a trailing P/E ratio of 69.9x, up from the previous P/E ratio of 59.3x. This compares to an average P/E of 39x in the Chemicals industry in China.
공시 • Jul 06KBC Corporation, Ltd. to Report First Half, 2020 Results on Aug 12, 2020KBC Corporation, Ltd. announced that they will report first half, 2020 results on Aug 12, 2020